Author

Etienne Lengline

Assistance publique hopitaux de paris H

Biography

Etienne Lengline is  working  at Adolescents and Yound Adult Hematology unit In Saint Louis Hospital, Paris at France. International experience includes various programs, contributions and participation in different countries for diverse fields of study and interests reflect in wide range of publications in various national and international journals  
Title
Cited by
Year
Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial
O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ...JAMA internal medicine 181 (1), 32-40, 2021202
812
2021
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ...The Lancet Respiratory Medicine 9 (3), 295-304, 2021202
241
2021
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ...The Lancet 396 (10266), 1885-1894, 2020202
190
2020
Complement C5 inhibition in patients with COVID-19-a promising target?
RP de Latour, A Bergeron, E Lengline, T Dupont, A Marchal, L Galicier, ...Haematologica 105 (12), 2847, 2020202
55
2020
Clinical phenotypes of critically ill COVID-19 patients
E Azoulay, L Zafrani, A Mirouse, E Lengliné, M Darmon, S ChevretIntensive Care Medicine 46, 1651-1652, 2020202
54
2020
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short-and long-term clinical outcomes: a large, retrospective …
M Stahl, RM Shallis, W Wei, P Montesinos, E Lengline, J Neukirchen, ...Leukemia 34 (12), 3149-3160, 2020202
48
2020
Epidemiology, clinical picture and long‐term outcomes of FIP1L1‐PDGFRA‐positive myeloid neoplasm with eosinophilia: Data from 151 patients
J Rohmer, A Couteau‐Chardon, J Trichereau, K Panel, C Gesquiere, ...American Journal of Hematology 95 (11), 1314-1323, 2020202
36
2020
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
J Delaleu, B Deniau, M Battistella, A de Masson, B Bensaid, M Jachiet, ...The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2777-2779. e1, 2020202
32
2020
Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital
O Peyrony, S Ellouze, JP Fontaine, M Thegat-Le Cam, M Salmona, ...International Journal of Hygiene and Environmental Health 230, 113600, 2020202
29
2020
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial
X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ...The Lancet Rheumatology 4 (1), e24-e32, 2022202
29
2022
Identification of distinct immunophenotypes in critically ill coronavirus disease 2019 patients
T Dupont, S Caillat-Zucman, V Fremeaux-Bacchi, F Morin, E Lengliné, ...Chest 159 (5), 1884-1893, 202
21
2021
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a …
R Benjamin, N Jain, MV Maus, N Boissel, C Graham, A Jozwik, D Yallop, ...The Lancet Haematology 9 (11), e833-e843, 2022202
17
2022
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment
E Lengliné, J Peron, A Vanier, F Gueyffier, S Kouzan, P Dufour, B Guillot, ...The Lancet Oncology 22 (10), e430-e434, 2021202
16
2021
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy
M Cerrano, M Duchmann, R Kim, L Vasseur, P Hirsch, X Thomas, ...Leukemia 35 (3), 712-723, 2021202
14
2021
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy
RM Shallis, M Stahl, W Wei, P Montesinos, E Lengline, J Neukirchen, ...Leukemia & lymphoma 61 (5), 1220-1225, 2020202
13
2020
Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: The Allo-GRRR-OH score
C Pichereau, E Lengliné, S Valade, D Michonneau, E Ghrenassia, ...Bone Marrow Transplantation 55 (10), 1966-1974, 2020202
13
2020
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
M Simonin, A Schmidt, C Bontoux, MÉ Dourthe, E Lengliné, GP Andrieu, ...Journal of hematology & oncology 14 (1), 1-7, 2021202
13
2021
Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
AS Del Galy, A Marouf, E Raffoux, M Robin, D Michonneau, M Sébert, ...Leukemia 35 (1), 225-228, 2021202
12
2021
Critically ill cancer patient’s resuscitation: A Belgian/French societies’ consensus conference
AP Meert, S Wittnebel, S Holbrechts, AC Toffart, JJ Lafitte, M Piagnerelli, ...Intensive care medicine 47, 1063-1077, 2021202
11
2021
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia
M Sebert, S Gachet, T Leblanc, A Rousseau, O Bluteau, R Kim, ...Cell stem cell 30 (2), 153-170. e, 2023202
9
2023

Referred From: https://scholar.google.fr/citations?user=GprkodsAAAAJ&hl=fr

Cited by
Citations 4337
h-index 30
i10-index 61
Recommended Journals
Open Access Journals